首页 | 本学科首页   官方微博 | 高级检索  
     

厄贝沙坦多晶型X-射线粉末衍射定量分析
引用本文:楼永军, 左丽丽. 厄贝沙坦多晶型X-射线粉末衍射定量分析[J]. 中国现代应用药学, 2021, 38(12): 1490-1492. DOI: 10.13748/j.cnki.issn1007-7693.2021.12.014
作者姓名:楼永军  左丽丽
作者单位:浙江省食品药品检验研究院, 国家药品监督管理局仿制药评价关键技术重点实验室, 杭州 310052;浙江工业大学, 杭州 310014
基金项目:“重大新药创制”国家科技重大专项(2017ZX09101001);浙江省食品药品检验研究院重点项目[浙食药检(2013)38号]
摘    要:目的 建立厄贝沙坦晶型原料药的晶型含量分析方法,为药品晶型质量控制提供技术支撑.方法 采用X-射线粉末衍射法表征厄贝沙坦晶型A和晶型B.分别选取晶型A的特征衍射峰2θ=4.65°和晶型B的特征衍射峰2θ=-7.99°的峰面积比值为定量参数,建立标准曲线检测晶型B的含量.结果 晶型B在晶型A和晶型B混合物中含量为2%~5...

关 键 词:厄贝沙坦  晶型A  晶型B  X-射线粉末衍射  标准曲线  定量分析
收稿时间:2020-04-07

Quantitative Determination of Irbesartan Polymorphs by X-ray Powder Diffraction
LOU Yongjun, ZUO Lili. Quantitative Determination of Irbesartan Polymorphs by X-ray Powder Diffraction[J]. Chinese Journal of Modern Applied Pharmacy, 2021, 38(12): 1490-1492. DOI: 10.13748/j.cnki.issn1007-7693.2021.12.014
Authors:LOU Yongjun  ZUO Lili
Affiliation:Zhejiang Institute for Food and Drug Control, NMPA Key Laboratory for Core Technology of Generic Drug Evaluation, Hangzhou 310052, China;Zhejiang University of Technology, Hangzhou 310014, China
Abstract:OBJECTIVE To establish a method for the determination of the contents of irbesartan polymorphs and to provide technical support for the quality control of crystal forms. METHODS X-ray powder diffraction method was used to characterize form A and B of irbesartan. A standard curve method was developed by using the characteristic peak ratio of form A at 4.65° 2θ and form B at 7.99° 2θ as the quantitative parameters, and the content of form B was calculated by the standard curve. RESULTS The curve of form B in the mixtures of form A and B was linear over the range of 2%-50% with r of 0.999 5, the instrument precision was 4.7%, and the concentration of LOD was 1.12%(S/N=4.4). CONCLUSION The established method is accurate, simple, and can be used to determine the contents of form B in the mixtures of form A and B.
Keywords:irbesartan|form A|form B|X-ray powder diffraction|standard curve|quantitative determination
点击此处可从《中国现代应用药学》浏览原始摘要信息
点击此处可从《中国现代应用药学》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号